SP-0346 How may shorter fractionation schedules affect patient care?

Hypofractionated or Conventionally Fractionated Adjuvant Radiotherapy After Regional Lymph Node Dissection for High-Risk Stage III Melanoma

“…During the recent COVID-19 pandemic, the use of hypofractionation in cancer patients has been successfully expanded to minimise treatment time [20]. Finally, adjuvant radiotherapy remains an important option for patients who are not eligible for adjuvant systemic therapy (such as those patients with a history of significant autoimmune disease or transplantation).…”